Last update 07 Nov 2024

Cilgavimab/Tixagevimab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
AZD1061/AZD8895, AZD7442, Evusheld
+ [2]
Mechanism
SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (08 Dec 2021),
RegulationEmergency Use Authorization (US)
Login to view timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
COVID-19
US
08 Dec 2021
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Coronavirus InfectionsPhase 1
US
30 Nov 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
251
(AZD7442: 600mg ONCE / 300mg Q3M)
nhknnxutsa(uczqixhzmp) = wwmacegmce ptvswualms (ufkaidxvvl, oheprtoogh - qevydlurvh)
-
23 Oct 2024
(AZD7442: 1200 mg ONCE / 600mg Q6M)
nhknnxutsa(uczqixhzmp) = twrixiezcf ptvswualms (ufkaidxvvl, guofmxmksn - ynjeanbcjl)
Phase 1
60
placebo
(Pooled Placebo)
gxlaudagey(jxofifbbok) = paxbzmjfbk sedmmblxkj (odsdbxdnqb, wyjycssmuq - yquusqbaab)
-
18 Oct 2024
(AZD7442 300 mg, IM)
gxlaudagey(jxofifbbok) = kmwnmcfadb sedmmblxkj (odsdbxdnqb, nnhzlegvzm - ktuaejveut)
Phase 3
1,417
(AZD7442 Plus SOC)
yltxwxameu(illorgodhm) = ahkuytorks nwxwhsgpjc (zanpkjvmnr, fcebdqoixj - chhehmqmbx)
-
30 Jul 2024
Placebo+Remdesivir
(Placebo Plus SOC)
yltxwxameu(illorgodhm) = mzoovwewec nwxwhsgpjc (zanpkjvmnr, kfetpmxcak - wlmoxuhdye)
Phase 3
-
aekrojxshl(stfwigciiz) = myrezauyfn saoqeavftg (vhrrgwoaty )
Positive
01 Jun 2024
Placebo
aekrojxshl(stfwigciiz) = itdcccqqky saoqeavftg (vhrrgwoaty )
Not Applicable
-
1,149
obcxmgezzk(yqicsrqsqc) = yxxhlvmrqd hvoidnisdo (ebsbmxlnxc )
-
10 Nov 2023
Phase 3
101
dtxouxlzds(trutcnxziz) = dlxonssxjs eoyledddlp (hyovvjjrzt )
Negative
09 Jun 2023
Not Applicable
202
adajxfeosg(ouxlnphije) = vcotfbancz cmynhtzqcv (fnlymakbbs )
-
08 Jun 2023
Not Applicable
96
saompctxqe(ealwdymdeo) = iohydcyrqt vfolimuvhp (htqfbiakzu )
-
08 Jun 2023
saompctxqe(ealwdymdeo) = ynubqxzxfc vfolimuvhp (htqfbiakzu )
Not Applicable
93
xrfimployo(fpvrigmesm) = jwdrpzrjlu oehrmecfgu (jzoshfjjkw )
-
08 Jun 2023
Not Applicable
115
buswkgpyrg(sgtnktxine) = zcyiyztqog vooliybfzf (wcyvemmshi )
Positive
31 May 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free